Sunday, April 19, 2020 3:20:27 PM
SYMBOL/ # ISSUED/ EXER. PRICE/ EXPIRES
PAT.WT / 3.3M/ 1.25/ 7/13/20
PAT.WT.C / 18.4M/ 3.25/ 24 MONTHS
PAT.WT.B/PTONF / 12.65M/ 2.40/ 2/22/21
PAT.WT.A/PTRTF / 9.6M/ 1.70/ 10/31/20
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM